Global Multiplex Antigen Microarray Market Research Report 2025

Publication ID:

PB504250695

Publication Date:

April 28, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Multiplex Antigen Microarray was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents鈥� wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Multiplex Antigen Microarray, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiplex Antigen Microarray.
The Multiplex Antigen Microarray market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Multiplex Antigen Microarray market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multiplex Antigen Microarray companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Thermo Fisher Scientific
Bio-Rad Laboratories
Agilent Technologies
PerkinElmer
Intuitive Biosciences
GE Healthcare
BioChain
Sengenics
Applied Microarrays
US Biomax
Segment by Type
Autoantibody Detection
Biomarker Profiling
Segment by Application
Drug Discovery
Therapeutics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multiplex Antigen Microarray company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiplex Antigen Microarray Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Autoantibody Detection
1.2.3 Biomarker Profiling
1.3 Market by Application
1.3.1 Global Multiplex Antigen Microarray Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Discovery
1.3.3 Therapeutics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multiplex Antigen Microarray Market Perspective (2020-2031)
2.2 Global Multiplex Antigen Microarray Growth Trends by Region
2.2.1 Global Multiplex Antigen Microarray Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Multiplex Antigen Microarray Historic Market Size by Region (2020-2025)
2.2.3 Multiplex Antigen Microarray Forecasted Market Size by Region (2026-2031)
2.3 Multiplex Antigen Microarray Market Dynamics
2.3.1 Multiplex Antigen Microarray Industry Trends
2.3.2 Multiplex Antigen Microarray Market Drivers
2.3.3 Multiplex Antigen Microarray Market Challenges
2.3.4 Multiplex Antigen Microarray Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multiplex Antigen Microarray Players by Revenue
3.1.1 Global Top Multiplex Antigen Microarray Players by Revenue (2020-2025)
3.1.2 Global Multiplex Antigen Microarray Revenue Market Share by Players (2020-2025)
3.2 Global Multiplex Antigen Microarray Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Multiplex Antigen Microarray Revenue
3.4 Global Multiplex Antigen Microarray Market Concentration Ratio
3.4.1 Global Multiplex Antigen Microarray Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiplex Antigen Microarray Revenue in 2024
3.5 Global Key Players of Multiplex Antigen Microarray Head office and Area Served
3.6 Global Key Players of Multiplex Antigen Microarray, Product and Application
3.7 Global Key Players of Multiplex Antigen Microarray, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiplex Antigen Microarray Breakdown Data by Type
4.1 Global Multiplex Antigen Microarray Historic Market Size by Type (2020-2025)
4.2 Global Multiplex Antigen Microarray Forecasted Market Size by Type (2026-2031)
5 Multiplex Antigen Microarray Breakdown Data by Application
5.1 Global Multiplex Antigen Microarray Historic Market Size by Application (2020-2025)
5.2 Global Multiplex Antigen Microarray Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Multiplex Antigen Microarray Market Size (2020-2031)
6.2 North America Multiplex Antigen Microarray Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Multiplex Antigen Microarray Market Size by Country (2020-2025)
6.4 North America Multiplex Antigen Microarray Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multiplex Antigen Microarray Market Size (2020-2031)
7.2 Europe Multiplex Antigen Microarray Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Multiplex Antigen Microarray Market Size by Country (2020-2025)
7.4 Europe Multiplex Antigen Microarray Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multiplex Antigen Microarray Market Size (2020-2031)
8.2 Asia-Pacific Multiplex Antigen Microarray Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Multiplex Antigen Microarray Market Size by Region (2020-2025)
8.4 Asia-Pacific Multiplex Antigen Microarray Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Multiplex Antigen Microarray Market Size (2020-2031)
9.2 Latin America Multiplex Antigen Microarray Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Multiplex Antigen Microarray Market Size by Country (2020-2025)
9.4 Latin America Multiplex Antigen Microarray Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multiplex Antigen Microarray Market Size (2020-2031)
10.2 Middle East & Africa Multiplex Antigen Microarray Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Multiplex Antigen Microarray Market Size by Country (2020-2025)
10.4 Middle East & Africa Multiplex Antigen Microarray Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Multiplex Antigen Microarray Introduction
11.1.4 Illumina Revenue in Multiplex Antigen Microarray Business (2020-2025)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Multiplex Antigen Microarray Introduction
11.2.4 Thermo Fisher Scientific Revenue in Multiplex Antigen Microarray Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Multiplex Antigen Microarray Introduction
11.3.4 Bio-Rad Laboratories Revenue in Multiplex Antigen Microarray Business (2020-2025)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Multiplex Antigen Microarray Introduction
11.4.4 Agilent Technologies Revenue in Multiplex Antigen Microarray Business (2020-2025)
11.4.5 Agilent Technologies Recent Development
11.5 PerkinElmer
11.5.1 PerkinElmer Company Details
11.5.2 PerkinElmer Business Overview
11.5.3 PerkinElmer Multiplex Antigen Microarray Introduction
11.5.4 PerkinElmer Revenue in Multiplex Antigen Microarray Business (2020-2025)
11.5.5 PerkinElmer Recent Development
11.6 Intuitive Biosciences
11.6.1 Intuitive Biosciences Company Details
11.6.2 Intuitive Biosciences Business Overview
11.6.3 Intuitive Biosciences Multiplex Antigen Microarray Introduction
11.6.4 Intuitive Biosciences Revenue in Multiplex Antigen Microarray Business (2020-2025)
11.6.5 Intuitive Biosciences Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Details
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Multiplex Antigen Microarray Introduction
11.7.4 GE Healthcare Revenue in Multiplex Antigen Microarray Business (2020-2025)
11.7.5 GE Healthcare Recent Development
11.8 BioChain
11.8.1 BioChain Company Details
11.8.2 BioChain Business Overview
11.8.3 BioChain Multiplex Antigen Microarray Introduction
11.8.4 BioChain Revenue in Multiplex Antigen Microarray Business (2020-2025)
11.8.5 BioChain Recent Development
11.9 Sengenics
11.9.1 Sengenics Company Details
11.9.2 Sengenics Business Overview
11.9.3 Sengenics Multiplex Antigen Microarray Introduction
11.9.4 Sengenics Revenue in Multiplex Antigen Microarray Business (2020-2025)
11.9.5 Sengenics Recent Development
11.10 Applied Microarrays
11.10.1 Applied Microarrays Company Details
11.10.2 Applied Microarrays Business Overview
11.10.3 Applied Microarrays Multiplex Antigen Microarray Introduction
11.10.4 Applied Microarrays Revenue in Multiplex Antigen Microarray Business (2020-2025)
11.10.5 Applied Microarrays Recent Development
11.11 US Biomax
11.11.1 US Biomax Company Details
11.11.2 US Biomax Business Overview
11.11.3 US Biomax Multiplex Antigen Microarray Introduction
11.11.4 US Biomax Revenue in Multiplex Antigen Microarray Business (2020-2025)
11.11.5 US Biomax Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Illumina
Thermo Fisher Scientific
Bio-Rad Laboratories
Agilent Technologies
PerkinElmer
Intuitive Biosciences
GE Healthcare
BioChain
Sengenics
Applied Microarrays
US Biomax

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂